Functional characterization of p53 molecules expressed in human squamous cell carcinomas of the head and neck

William Andrew Yeudall, Judit Jakus, John F. Ensley, Keith C. Robbins

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Mutation of the p53 tumor suppressor gene has been demonstrated in a large proportion of human head and neck squamous cell carcinomas (H NSGCs) and has been assumed to play a role in the pathogenesis of these tumors, although no formal evidence of functional aberration has been demonstrated. In this study, we isolated cDNA clones encoding the entire p53 coding region from six human HNSCC cell lines that showed aberrant patterns of p53 expression in the parental cells, analyzed their nucleotide sequences, and characterized their function in vivo. cDNAs cloned from four cell lines harbored alterations within the p53 coding sequence (one missense mutation, one missense mutation plus in-frame deletion, one splice donor mutation, and a 1-nt insertion). HN30 cells, which contained wild-type p53 nucleotide sequences, showed a high constitutive level of protein expression. HN26 cells contained wild-type coding sequences but did not express the 53-kDa protein, although the mRNA was transcribed and a molecule of increased molecular mass (70 kDa) was observed by western blotting. Functional studies revealed that none of the four proteins encoded by mutant cDNAs were able to transactivate expression of a reporter plasmid containing a wild-type p53 consensus binding site when cotransfected into p53-null cells, whereas molecules encoded by wild-type p53 cDNAs increased reporter gene expression about a hundredfold over uninduced levels. Co-expression of each mutant cDNA with wi[dtype p53 cDNA and a wild-type p53-responsive reporter gene demonstrated that each of the proteins encoded by mutant cDNAs harbored some degree of inhibitory activity that varied depending on the mutation present. Thus, aberrant p53 function as a result of mutation or altered expression characterizes oral squamous cell carcinomas. The inhibitory activity of these molecules may be a mechanism for deregulation of the function of co-expressed wild-type p53 that may be of importance during the early stages of tumor development.

Original languageEnglish (US)
Pages (from-to)89-96
Number of pages8
JournalMolecular Carcinogenesis
Volume18
Issue number2
DOIs
StatePublished - Feb 1 1997
Externally publishedYes

Fingerprint

Complementary DNA
Mutation
Missense Mutation
Mutant Proteins
Reporter Genes
Cell Line
Null Lymphocytes
Carcinoma, squamous cell of head and neck
Tumor Suppressor Genes
Squamous Cell Carcinoma
Neoplasms
Proteins
Plasmids
Clone Cells
Western Blotting
Binding Sites
Gene Expression
Messenger RNA

Keywords

  • Gene mutation
  • Oral cancer
  • Squamous cell carcinoma
  • Transactivation
  • Transcription
  • p53

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research

Cite this

Functional characterization of p53 molecules expressed in human squamous cell carcinomas of the head and neck. / Yeudall, William Andrew; Jakus, Judit; Ensley, John F.; Robbins, Keith C.

In: Molecular Carcinogenesis, Vol. 18, No. 2, 01.02.1997, p. 89-96.

Research output: Contribution to journalArticle

@article{7ef289f930c247c5b2c7a4e279eca48b,
title = "Functional characterization of p53 molecules expressed in human squamous cell carcinomas of the head and neck",
abstract = "Mutation of the p53 tumor suppressor gene has been demonstrated in a large proportion of human head and neck squamous cell carcinomas (H NSGCs) and has been assumed to play a role in the pathogenesis of these tumors, although no formal evidence of functional aberration has been demonstrated. In this study, we isolated cDNA clones encoding the entire p53 coding region from six human HNSCC cell lines that showed aberrant patterns of p53 expression in the parental cells, analyzed their nucleotide sequences, and characterized their function in vivo. cDNAs cloned from four cell lines harbored alterations within the p53 coding sequence (one missense mutation, one missense mutation plus in-frame deletion, one splice donor mutation, and a 1-nt insertion). HN30 cells, which contained wild-type p53 nucleotide sequences, showed a high constitutive level of protein expression. HN26 cells contained wild-type coding sequences but did not express the 53-kDa protein, although the mRNA was transcribed and a molecule of increased molecular mass (70 kDa) was observed by western blotting. Functional studies revealed that none of the four proteins encoded by mutant cDNAs were able to transactivate expression of a reporter plasmid containing a wild-type p53 consensus binding site when cotransfected into p53-null cells, whereas molecules encoded by wild-type p53 cDNAs increased reporter gene expression about a hundredfold over uninduced levels. Co-expression of each mutant cDNA with wi[dtype p53 cDNA and a wild-type p53-responsive reporter gene demonstrated that each of the proteins encoded by mutant cDNAs harbored some degree of inhibitory activity that varied depending on the mutation present. Thus, aberrant p53 function as a result of mutation or altered expression characterizes oral squamous cell carcinomas. The inhibitory activity of these molecules may be a mechanism for deregulation of the function of co-expressed wild-type p53 that may be of importance during the early stages of tumor development.",
keywords = "Gene mutation, Oral cancer, Squamous cell carcinoma, Transactivation, Transcription, p53",
author = "Yeudall, {William Andrew} and Judit Jakus and Ensley, {John F.} and Robbins, {Keith C.}",
year = "1997",
month = "2",
day = "1",
doi = "10.1002/(SICI)1098-2744(199702)18:2<89::AID-MC4>3.0.CO;2-L",
language = "English (US)",
volume = "18",
pages = "89--96",
journal = "Molecular Carcinogenesis",
issn = "0899-1987",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Functional characterization of p53 molecules expressed in human squamous cell carcinomas of the head and neck

AU - Yeudall, William Andrew

AU - Jakus, Judit

AU - Ensley, John F.

AU - Robbins, Keith C.

PY - 1997/2/1

Y1 - 1997/2/1

N2 - Mutation of the p53 tumor suppressor gene has been demonstrated in a large proportion of human head and neck squamous cell carcinomas (H NSGCs) and has been assumed to play a role in the pathogenesis of these tumors, although no formal evidence of functional aberration has been demonstrated. In this study, we isolated cDNA clones encoding the entire p53 coding region from six human HNSCC cell lines that showed aberrant patterns of p53 expression in the parental cells, analyzed their nucleotide sequences, and characterized their function in vivo. cDNAs cloned from four cell lines harbored alterations within the p53 coding sequence (one missense mutation, one missense mutation plus in-frame deletion, one splice donor mutation, and a 1-nt insertion). HN30 cells, which contained wild-type p53 nucleotide sequences, showed a high constitutive level of protein expression. HN26 cells contained wild-type coding sequences but did not express the 53-kDa protein, although the mRNA was transcribed and a molecule of increased molecular mass (70 kDa) was observed by western blotting. Functional studies revealed that none of the four proteins encoded by mutant cDNAs were able to transactivate expression of a reporter plasmid containing a wild-type p53 consensus binding site when cotransfected into p53-null cells, whereas molecules encoded by wild-type p53 cDNAs increased reporter gene expression about a hundredfold over uninduced levels. Co-expression of each mutant cDNA with wi[dtype p53 cDNA and a wild-type p53-responsive reporter gene demonstrated that each of the proteins encoded by mutant cDNAs harbored some degree of inhibitory activity that varied depending on the mutation present. Thus, aberrant p53 function as a result of mutation or altered expression characterizes oral squamous cell carcinomas. The inhibitory activity of these molecules may be a mechanism for deregulation of the function of co-expressed wild-type p53 that may be of importance during the early stages of tumor development.

AB - Mutation of the p53 tumor suppressor gene has been demonstrated in a large proportion of human head and neck squamous cell carcinomas (H NSGCs) and has been assumed to play a role in the pathogenesis of these tumors, although no formal evidence of functional aberration has been demonstrated. In this study, we isolated cDNA clones encoding the entire p53 coding region from six human HNSCC cell lines that showed aberrant patterns of p53 expression in the parental cells, analyzed their nucleotide sequences, and characterized their function in vivo. cDNAs cloned from four cell lines harbored alterations within the p53 coding sequence (one missense mutation, one missense mutation plus in-frame deletion, one splice donor mutation, and a 1-nt insertion). HN30 cells, which contained wild-type p53 nucleotide sequences, showed a high constitutive level of protein expression. HN26 cells contained wild-type coding sequences but did not express the 53-kDa protein, although the mRNA was transcribed and a molecule of increased molecular mass (70 kDa) was observed by western blotting. Functional studies revealed that none of the four proteins encoded by mutant cDNAs were able to transactivate expression of a reporter plasmid containing a wild-type p53 consensus binding site when cotransfected into p53-null cells, whereas molecules encoded by wild-type p53 cDNAs increased reporter gene expression about a hundredfold over uninduced levels. Co-expression of each mutant cDNA with wi[dtype p53 cDNA and a wild-type p53-responsive reporter gene demonstrated that each of the proteins encoded by mutant cDNAs harbored some degree of inhibitory activity that varied depending on the mutation present. Thus, aberrant p53 function as a result of mutation or altered expression characterizes oral squamous cell carcinomas. The inhibitory activity of these molecules may be a mechanism for deregulation of the function of co-expressed wild-type p53 that may be of importance during the early stages of tumor development.

KW - Gene mutation

KW - Oral cancer

KW - Squamous cell carcinoma

KW - Transactivation

KW - Transcription

KW - p53

UR - http://www.scopus.com/inward/record.url?scp=0030997982&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030997982&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1098-2744(199702)18:2<89::AID-MC4>3.0.CO;2-L

DO - 10.1002/(SICI)1098-2744(199702)18:2<89::AID-MC4>3.0.CO;2-L

M3 - Article

C2 - 9049184

AN - SCOPUS:0030997982

VL - 18

SP - 89

EP - 96

JO - Molecular Carcinogenesis

JF - Molecular Carcinogenesis

SN - 0899-1987

IS - 2

ER -